Towards personalized antibody cancer therapy: development of a microfluidic cell culture device for antibody selection-Reference-Cited by-同舟云学术

Towards personalized antibody cancer therapy: development of a microfluidic cell culture device for antibody selection

Published:2022 Issue:23 Volume:22 Page:4717-4728
ISSN:1473-0197
Container-title:Lab on a Chip
language:en
Short-container-title:Lab Chip

Author:

Condelipes Pedro G. M.¹²^ORCID,Fontes Pedro Mendes¹³^ORCID,Godinho-Santos Ana³,Brás Eduardo J. S.¹⁴,Marques Vanda³,Afonso Marta B.³,Rodrigues Cecília M. P.³,Chu Virginia¹,Gonçalves João³,Conde João Pedro¹²

Affiliation:

1. Instituto de Engenharia de Sistemas e Computadores – Microsistemas e Nanotecnologias (INESC MN), Lisbon, Portugal

2. Department of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal

3. Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal

4. IBB – Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal

Abstract

Easy-to-use PDMS/polystyrene microfluidic device for the perfused culture of cancer cells and study of interaction-based therapies, namely phage-cell interactions.

Funder

Programa Operacional Temático Factores de Competitividade

Fundação para a Ciência e a Tecnologia

Universidade de Lisboa

Publisher

Royal Society of Chemistry (RSC)

Subject

Biomedical Engineering,General Chemistry,Biochemistry,Bioengineering

Link

http://pubs.rsc.org/en/content/articlepdf/2022/LC/D2LC00918H

Reference76 articles.

1. Monoclonal antibody successes in the clinic

2. Monoclonal antibody therapy of cancer

3. Antibody therapy of cancer

4. Development of therapeutic antibodies for the treatment of diseases

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A mini review on recent progress of microfluidic systems for antibody development;Journal of Diabetes & Metabolic Disorders;2024-01-18

2. Microfluidic Detection of Adenylate Kinase as a Cell Damage Biomarker;Chemosensors;2023-04-02

3. Human liver organoids: From generation to applications;Hepatology;2023-02-27